Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mika Sakurai is active.

Publication


Featured researches published by Mika Sakurai.


Nihon rinsho. Japanese journal of clinical medicine | 2008

Anti-IL-6 Receptor Antibody

Tomoyuki Igawa; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Atsuhiko Maeda


Archive | 2009

Improved antibody molecule

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi


Archive | 2009

Antibody molecules that bind to il-6 receptor

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi


Archive | 2010

Pharmaceutical formulation containing improved antibody molecules

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi; Chifumi Moriyama; Akira Hayasaka


Archive | 2009

IMPROVED ANTIBODY MOLECULE AGAINST IL-6 RECEPTOR

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi


Archive | 2014

Antigen-binding molecule containing modified antibody variable region

Tomoyuki Igawa; Shojiro Kadono; Naoka Hironiwa; Mika Sakurai


Journal of Nuclear Cardiology | 2007

1.47: Changes in myocardial perfusion and function after PCI in patients with chronic total occlusion of a coronary artery disease without prior MI

Yuko Kawai; Youichi Nozaki; Mika Sakurai; Nagara Tamaki


Archive | 2016

Cytotoxic induction therapeutic agent

淳一 根津; Jun-ichi Nezu; 敦 成田; Atsushi Narita; 敬弘 石黒; Takahiro Ishiguro; 実香 櫻井; Mika Sakurai; 宙丈 白岩; Hirotake Shiraiwa; 奈緒香 廣庭; Naoka Hironiwa; 智之 井川; Tomoyuki Igawa; 由美子 川合; Yumiko Kawai


Archive | 2014

Molécule se liant à l'antigène contenant une région variable d'anticorps modifiée

智之 井川; Tomoyuki Igawa; 正次郎 門野; Shojiro Kadono; 奈緒香 廣庭; Naoka Hironiwa; 実香 櫻井; Mika Sakurai


Archive | 2010

Formulation pharmaceutique contenant des molécules d'anticorps améliorées

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi; Chifumi Moriyama; Akira Hayasaka

Collaboration


Dive into the Mika Sakurai's collaboration.

Top Co-Authors

Avatar

Tomoyuki Igawa

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atsuhiko Maeda

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tetsuo Kojima

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Shinya Ishii

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Youichi Nozaki

Memorial Hospital of South Bend

View shared research outputs
Researchain Logo
Decentralizing Knowledge